Dr. Rhonda Emily Alkatib, MD

Dr. Alkatib practices at Allergy Partners of California, Inc. in San Diego, California.

Dr. Alkatib's NPI, 1417363086, was assigned on July 3, 2014. Dr. Alkatib's California license number on file is A163910.

Dr. Alkatib's primary practice is Allergy Partners of California, Inc., at 2655 Camino Del Rio N, San Diego, CA 92108 in San Diego County. The practice phone is (619) 286-6687.

Dr. Alkatib's primary practice is Allergy Partners of California, Inc. in San Diego, California. The medical group on file is Allergy Partners of California Central Coast. Dmand AI also links Dr. Alkatib to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alkatib practices. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Alkatib's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Alkatib is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dr. Alkatib has a license on file in California.

Dmand AI lists asthma, chronic nasal allergies, hives and immune deficiency disease among the conditions Dr. Alkatib treats.

CMS data shows 3,571 Medicare services from Dr. Alkatib across 10 procedure codes in 2024, for 107 Medicare patients. Medicare paid $29,180 for them. Every service was in an office.

CMS counts 107 Medicare patients who saw Dr. Alkatib in 2024. The largest group is 65 to 74, with 57 patients. 73% of them have high cholesterol, and 65% have high blood pressure. 36% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alkatib's median patient age at 42, with 67% women.

In 2024, Dr. Alkatib wrote 694 Medicare Part D claims for 127 patients. 54% of them were for generic drugs. CMS names the drug for 570 of them, across 21 drugs with 11 or more claims each, at $650,745 in total drug cost. In 2023, CMS named 413 claims across 17 drugs.

Dr. Alkatib accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Alkatib in 2018. Dr. Alkatib's most frequent co-authors are Tara Friedel Carr, MD and Monica T. Kraft.

CMS Open Payments shows 610 general payments to Dr. Alkatib from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. Genentech, Inc. paid the most, $6,633.

Dr. Alkatib is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.